{"id":53970,"date":"2023-02-15T22:04:38","date_gmt":"2023-02-15T21:04:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/"},"modified":"2023-02-15T22:04:38","modified_gmt":"2023-02-15T21:04:38","slug":"loyal-appoints-blake-scholl-to-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/","title":{"rendered":"Loyal Appoints Blake Scholl to its Board of Directors"},"content":{"rendered":"
\n

\nScholl brings extensive entrepreneurial experience and technical innovation to help Loyal deliver world\u2019s first FDA-approved longevity drug<\/i>\n<\/p>\n

SAN FRANCISCO–(BUSINESS WIRE)–Loyal<\/a>, a biotech company developing the world\u2019s first drugs intended to extend the healthy lifespan of dogs, announced today that Blake Scholl has joined as an Independent Director. Scholl brings over 20 years of successful startup, technical, and commercial experience to Loyal as the company progresses towards FDA approval and bringing their first dog aging drugs to vets and pet parents.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nBlake Scholl is the Founder and CEO of Boom Supersonic<\/a>, the company building the world\u2019s fastest airliner. Boom has built XB-1, history\u2019s first independently-developed supersonic jet, and taken orders and pre-orders for Overture, its supersonic passenger airliner. Prior to founding Boom in 2014, Blake held leadership roles at Amazon<\/a> and Groupon<\/a> and co-founded mobile technology startup Kima Labs.\n<\/p>\n

\nBlake joins existing Board of Directors Laura Deming of The Longevity Fund and Celine Halioua, and Board Observers Josh Kopelman of First Round Capital and Greg Rosen of Box Group.\n<\/p>\n

\n\u201cI\u2019m extremely excited that Blake is joining Loyal\u2019s Board. Blake is fascinated with longevity science, has a strong passion for tackling big, important problems, and has invaluable experience bringing entirely new products to consumers,\u201d according to Loyal CEO and Founder, Celine Halioua. \u201cI look forward to learning from and working with Blake.\u201d\n<\/p>\n

\n\u201cTime is one of the most valuable commodities we have, which is why I\u2019m inspired by Loyal\u2019s mission to extend the time we have with our best friends, and increase their healthspan,\u201d said Blake Scholl. \u201cI\u2019m excited to contribute my experience to their efforts.\u201d\n<\/p>\n

\nScholl\u2019s appointment comes after key company milestones in the last year, including administering the first aging drug to a companion dog\u2013 Josie, a seven-year-old Mastiff\u2013 and successfully completing canine efficacy studies for both of their drug programs: LOY001<\/a>, intended for lifespan extension for large dogs, and LOY002<\/a>, intended for lifespan extension for old dogs of any size. Loyal also recently concluded its X-Thousand Dogs Study<\/a>, the largest dog epigenetics study in history, one of many efforts to quantify the processes of pathological versus healthy aging.\n<\/p>\n

\nLoyal is currently recruiting veterinary practices<\/a> to participate in its pivotal study for LOY-002.\n<\/p>\n

\nAbout Loyal<\/b>\n<\/p>\n

\nLoyal is a biotech startup developing the first drugs intended to help dogs live longer, healthier lives. By targeting and slowing the underlying ways dogs age, Loyal hopes to extend healthy lifespan by reducing or delaying mortality due to age-associated diseases improving dogs\u2019 quality of life and extending their lifespan.\n<\/p>\n

\nLoyal\u2019s work is backed by decades of research and their team of experts in dog health and longevity is dedicated to expanding upon this research and developing better ways to quantify and improve the aging process in dogs.\n<\/p>\n

\nThe clinical-stage veterinary medicine company has two distinct products in their drug pipeline. The first aims to support healthy aging in older dogs of nearly every size and breed. The second hopes to address the longevity of large-breed dogs.\n<\/p>\n

\nFollow Loyal on social: Facebook<\/a> \/ LinkedIn<\/a> \/ Twitter<\/a> \/ Instagram<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTim Smith
\n
Element Public Relations
\n
415-350-3019
\n
tsmith@elementpr.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Scholl brings extensive entrepreneurial experience and technical innovation to help Loyal deliver world\u2019s first FDA-approved longevity drug SAN FRANCISCO–(BUSINESS WIRE)–Loyal, a biotech company developing the world\u2019s first drugs intended to extend the healthy lifespan of dogs, announced today that Blake Scholl has joined as an Independent Director. Scholl brings over 20 years of successful startup, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53970","6":"format-standard","7":"category-industry"},"yoast_head":"\nLoyal Appoints Blake Scholl to its Board of Directors - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Loyal Appoints Blake Scholl to its Board of Directors - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Scholl brings extensive entrepreneurial experience and technical innovation to help Loyal deliver world\u2019s first FDA-approved longevity drug SAN FRANCISCO–(BUSINESS WIRE)–Loyal, a biotech company developing the world\u2019s first drugs intended to extend the healthy lifespan of dogs, announced today that Blake Scholl has joined as an Independent Director. Scholl brings over 20 years of successful startup, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-15T21:04:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230215005837\/en\/1715152\/21\/BlakeScholl.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Loyal Appoints Blake Scholl to its Board of Directors\",\"datePublished\":\"2023-02-15T21:04:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/\"},\"wordCount\":531,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005837\\\/en\\\/1715152\\\/21\\\/BlakeScholl.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/\",\"name\":\"Loyal Appoints Blake Scholl to its Board of Directors - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005837\\\/en\\\/1715152\\\/21\\\/BlakeScholl.jpg\",\"datePublished\":\"2023-02-15T21:04:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005837\\\/en\\\/1715152\\\/21\\\/BlakeScholl.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005837\\\/en\\\/1715152\\\/21\\\/BlakeScholl.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/loyal-appoints-blake-scholl-to-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Loyal Appoints Blake Scholl to its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Loyal Appoints Blake Scholl to its Board of Directors - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Loyal Appoints Blake Scholl to its Board of Directors - Pharma Trend","og_description":"Scholl brings extensive entrepreneurial experience and technical innovation to help Loyal deliver world\u2019s first FDA-approved longevity drug SAN FRANCISCO–(BUSINESS WIRE)–Loyal, a biotech company developing the world\u2019s first drugs intended to extend the healthy lifespan of dogs, announced today that Blake Scholl has joined as an Independent Director. Scholl brings over 20 years of successful startup, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-15T21:04:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230215005837\/en\/1715152\/21\/BlakeScholl.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Loyal Appoints Blake Scholl to its Board of Directors","datePublished":"2023-02-15T21:04:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/"},"wordCount":531,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230215005837\/en\/1715152\/21\/BlakeScholl.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/","url":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/","name":"Loyal Appoints Blake Scholl to its Board of Directors - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230215005837\/en\/1715152\/21\/BlakeScholl.jpg","datePublished":"2023-02-15T21:04:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230215005837\/en\/1715152\/21\/BlakeScholl.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230215005837\/en\/1715152\/21\/BlakeScholl.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/loyal-appoints-blake-scholl-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Loyal Appoints Blake Scholl to its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53970"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53970\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}